Evolus (EOLS) Cash & Equivalents (2018 - 2026)
Evolus' Cash & Equivalents came in at $41.7 million for Q3 2026, down 4.2% from $43.52 million a year earlier and down 7.7% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Evolus' Cash & Equivalents was $53.83 million, down 38.1% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -12.1% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $86.95 million in FY2024 (+38.4%), $62.84 million in FY2023 (+16.5%), $53.92 million in FY2022 (-63.1%) and $146.26 million in FY2021 (+42.6%).
- The Q3 2026 figure represents the lowest quarterly Cash & Equivalents since Q3 2023.
- Year-over-year, Cash & Equivalents has declined for seven consecutive quarters, with an average decline of 21.3% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2022 (growth of 381.1%), and the weakest in Q1 2023 (a decline of 70.5%).
- Business Quant data shows EOLS's Cash & Equivalents at $45.17 million (Q2 2026), $49.79 million (Q1 2026) and $53.83 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Evolus | 450.43 Mn | 259.94 Mn | 50.69 Mn | 41.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 41.70 Mn |
| Jun 30, 2026 | 45.17 Mn |
| Mar 31, 2026 | 49.79 Mn |
| Dec 31, 2025 | 53.83 Mn |
| Sep 30, 2025 | 43.52 Mn |
| Jun 30, 2025 | 61.74 Mn |
| Mar 31, 2025 | 67.89 Mn |
| Dec 31, 2024 | 86.95 Mn |
| Sep 30, 2024 | 85.04 Mn |
| Jun 30, 2024 | 93.67 Mn |
| Mar 31, 2024 | 96.96 Mn |
| Dec 31, 2023 | 62.84 Mn |
| Sep 30, 2023 | 38.69 Mn |
| Jun 30, 2023 | 41.71 Mn |
| Mar 31, 2023 | 31.46 Mn |
| Dec 31, 2022 | 53.92 Mn |
| Sep 30, 2022 | 65.57 Mn |
| Jun 30, 2022 | 84.48 Mn |
| Mar 31, 2022 | 106.67 Mn |
| Dec 31, 2021 | 146.26 Mn |
API Access
Evolus Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();